Three Bioethical Debates in Sweden
2008 (English)In: Cambridge Quarterly of Healthcare Ethics, ISSN 0963-1801, E-ISSN 1469-2147, Vol. 17, 261-269 p.Article in journal (Refereed) Published
Three of the bioethical issues recently discussed in Sweden appear to be particularly interesting also to an international audience. A new law allowing restrictive use of preimplantation genetic diagnosis (PGD)/human leukocyte antigen (HLA) ("savior siblings") has been implemented, a new recommendation for the cessation of life-sustaining treatment has been issued, and the scope of individual responsibility for medical mistakes has been rather thoroughly discussed.
Place, publisher, year, edition, pages
2008. Vol. 17, 261-269 p.
IdentifiersURN: urn:nbn:se:kth:diva-86040DOI: 10.1017/S0963180108080316ISI: 000256286200002ScopusID: 2-s2.0-46749083888OAI: oai:DiVA.org:kth-86040DiVA: diva2:500355
QC 201202142012-02-132012-02-132012-02-14Bibliographically approved